"The Motoric Cognitive Risk Syndrome in the Quebec Population"

Active, not recruitingOBSERVATIONAL
Enrollment

1,741

Participants

Timeline

Start Date

December 7, 2016

Primary Completion Date

December 7, 2020

Study Completion Date

December 7, 2025

Conditions
Cognition Disorders in Old AgeDementia
Interventions
OTHER

Summarize of participants' characteristics using means and standard deviations or frequencies and percentages

First, prevalence of MCR syndrome will be determined by classifying participants into MCR and non-MCR syndrome groups. Second, between-group comparisons of participants' characteristics will be performed using unpaired t-test, Mann-Whitney, analysis of variance with LSD correction or Chi-square test, as appropriate. Third, multiple regressions will be performed to examine the association between MCR syndrome (dependent variable) and cardio-vascular risk factors and/or diseases (independent variables) adjusted on participants' characteristics. Fourth, the incidence of MCR syndrome during the follow-up period of NuAge study will be reported. Fifth, regression will be performed to examine the association between MCR syndrome (dependent variable) and cognitive decline as well cognitive impairment (independent variables, separated model) adjusted on participants' characteristics.

Trial Locations (1)

H3T 1E2

Jewish General Hospital, Montreal

All Listed Sponsors
lead

Jewish General Hospital

OTHER

NCT03633253 - "The Motoric Cognitive Risk Syndrome in the Quebec Population" | Biotech Hunter | Biotech Hunter